| | LOC129390903, RAD51C (L201V) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (L201P) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | LOC129390903, RAD51C (D202E) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (N203D) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | LOC129390903, RAD51C (H207R) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +4 more | |
| | LOC129390903, RAD51C (Y209fs) | Microsatellite (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | LOC129390903, RAD51C (H207Q) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (I208V) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (Y210*) | Single nucleotide variant (nonsense +1 more) | Hereditary breast ovarian cancer syndrome +5 more | GPathogenic/Likely pathogenic |
| | LOC129390903, RAD51C (R212G) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | LOC129390903, RAD51C (R212C) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | LOC129390903, RAD51C (R212H) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (R214C) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (R214H) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (D215G) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (T217S) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | LOC129390903, RAD51C (L219S) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (A221V) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | LOC129390903, RAD51C (Q222H) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Duplication (splice donor variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | LOC129390903, RAD51C (P227S) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | LOC129390903, RAD51C (P227L) | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | LOC129390903, RAD51C (D228G) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (F229L) | Single nucleotide variant (missense variant +1 more) | not specified +2 more | |
| | LOC129390903, RAD51C (L230F) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (S231*) | Single nucleotide variant (nonsense +1 more) | Fanconi anemia complementation group O +2 more | |
| | LOC129390903, RAD51C (S231L) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (E232D) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (S234*) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +3 more | |
| | LOC129390903, RAD51C (K235T) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome +3 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +3 more | |